Open Access
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study
Xiaowen Hou, Xiaoqiu Li, Xinhong Wang, Huisheng Chen
DOI: 10.1136/svn-2018-000148 Published 21 December 2018
Xiaowen Hou
Department of Neurology, General Hospital of Shen-Yang Military Region, Shenyang, China
Xiaoqiu Li
Department of Neurology, General Hospital of Shen-Yang Military Region, Shenyang, China
Xinhong Wang
Department of Neurology, General Hospital of Shen-Yang Military Region, Shenyang, China
Huisheng Chen
Department of Neurology, General Hospital of Shen-Yang Military Region, Shenyang, China

Submit a Response to This Article
No eLetters have been published for this article.
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study
Xiaowen Hou, Xiaoqiu Li, Xinhong Wang, Huisheng Chen
Stroke and Vascular Neurology Dec 2018, 3 (4) 263-267; DOI: 10.1136/svn-2018-000148